FDA Drug Application (203177) for BACITRACIN by XELLIA PHARMS APS

Back to FDA Applications sponsored by XELLIA PHARMS APS

Application Number203177
Product Number001
FormINJECTABLE;INJECTION
Dosage50,000 UNITS/VIAL
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameBACITRACIN
Active IngredientBACITRACIN



Back to FDA Applications sponsored by XELLIA PHARMS APS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.